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Synaptic transmissionThe development of neurons is precisely controlled. Nerve cells are born from progenitor cells,
migrate to their future target sites, extend dendrites and an axon to form synapses, and thus estab-
lish neural networks. All these processes are governed by multiple intracellular signaling cascades,
among which ubiquitylation has emerged as a potent regulatory principle that determines protein
function and turnover. Dysfunctions of E3 ubiquitin ligases or aberrant ubiquitin signaling con-
tribute to a variety of brain disorders like X-linked mental retardation, schizophrenia, autism or
Parkinson’s disease. In this review, we summarize recent ﬁndings about molecular pathways that
involve E3 ligases of the Homologous to E6-AP C-terminus (HECT) family and that control neurito-
genesis, neuronal polarity formation, and synaptic transmission.
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The human brain is composed of 100 billion neurons, each con-
nected to other neurons by on average 1000–10000 specialized
connections – synapses [1,2]. Our memories, emotions, and sen-
sory and motor processing all rely on synaptic transmission [3,4],
and the morphology and synaptic connectivity of individual nerve
cells that set the framework of the neuronal circuits [5,6].
Upon the formation of the neural tube, neuroepithelial cells
proliferate at the ventricular zone to subsequently give rise to
radial glial cells (RGCs). These span the entire cortical plate, con-
tacting the marginal and ventricular zones. RGCs retain the poten-
tial to self-renew to increase their pool, while their asymmetric
divisions produce premature neurons and intermediate progeni-
tors. In the subventricular zone, each intermediate progenitor cell
divides into two descendant neurons. Newly born nerve cells
migrate along RGC processes to distribute in the nascent cortex
in a laminar fashion. During their migration, neurons start extend-
ing an axon and multiple dendrites. Growing axons explore the
brain towards their postsynaptic target neurons to form immature
synapses. Upon the process of synaptogenesis and synapse elimi-
nation, the mature neural network is established [7,8].
The precisely ordered sequence of events described above leads
to the generation of fully functional neural networks. Hence, theindividual developmental steps have to be exquisitely controlled
to guarantee reliable network function. There are multiple interde-
pendent extracellular cues and cell intrinsic molecular pathways
that govern all aspects of neural development. The function and
homeostasis of proteins executing these processes are spatially
and temporally regulated by ubiquitylation. Recent advances in
the ﬁeld reveal that molecular consequences of protein ubiquityla-
tion are diverse and inﬂuence protein turnover and sorting, endo-
cytosis of transmembrane proteins, or DNA damage responses [7].
Protein ubiquitylation is a posttranslational modiﬁcation that is
executed by a cascade of enzymatic reactions. First, the 10kDa
globular protein ubiquitin is modiﬁed by the E1 activating enzyme
to form a high-energy bond with AMP. Ubiquitin activated in this
manner is then covalently conjugated via thioester bond to the cys-
teine residue of the E1 enzyme. Ubiquitin is then shuttled to the E2
ubiquitin conjugating enzyme, and subsequently coupled to the
target protein with the support of an E3 ubiquitin ligase. The ﬁnal
ubiquitylation step is the formation of an isopeptide bond between
the e-amino group of a lysine residue in the substrate protein and
the carboxyl group of the C-terminal glycine residue in ubiquitin.
Considering that one or two E1, about thirty E2, and around six
hundred E3 enzymes are encoded by the mammalian genome
and that E3 ubiquitin ligases recognize substrate proteins by speci-
ﬁc protein–protein interactions, E3 enzymes are the main media-
tors of the substrate speciﬁcity of ubiquitylation. Importantly,
protein ubiquitylation is a reversible reaction, and the removal of
ubiquitin from substrates is catalyzed by a family of proteases
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ubiquitin chains [9–15].
Proteins can be conjugated with a single ubiquitin moiety or be
multimono- or polyubiquitlyated. Polyubiquitylation engages one
or several of the seven lysine residues (Lys6, Lys11, Lys27, Lys29,
Lys33, Lys48, and Lys63) present in ubiquitin itself. The resulting
chains can have different forms, ranging from homotypic linkages
to forked conformations. Depending on the lysine residue utilized
for chain formation, the ubiquitin chains endow substrate proteins
with different functions or fates. Lysine-48 polyubiquitin chains
target substrate proteins for proteasomal degradation and have
long been considered to represent the majority of ubiquitin modi-
ﬁcations [16,17]. However, recent data show that Lys11- and
Lys63-linked polyubiquitin chains are similarly abundant in yeast
[18]. In the rat brain, Lys-48-, Lys-63- and Lys-11-linked chains
represent the major polyubiquitin species [19]. There is compelling
evidence that Lys63-linked polyubiquitin chains mediate endocy-
tosis and recycling of transmembrane proteins [20,21], and that
Lys11-linked polyubiquitin chains are involved in the endoplasmic
reticulum-associated degradation pathway [22].
Based on their mode of action, two families of E3 ligases are dis-
tinguished, i.e. the Really Interesting New Gene (RING) and the
Homologous to E6-AP C-terminus (HECT) type. Whereas RING type
enzymes bring the ubiquitin-E2 complex into the molecular vicin-
ity of the substrate and facilitate ubiquitin transfer directly from
the E2 enzyme to the substrate protein, HECT type ligases cova-
lently bind the ubiquitin via a cysteine residue in their catalytic
HECT domain and then shuttle it onto the target molecule. The vast
majority of human E3 enzymes belong to the RING family while
only 28 are of the HECT type [23–25].
HECT type ubiquitin ligases all share a homologous C-terminal
HECT domain, composed of the N-terminal E2 enzyme-binding
lobe and a smaller C-terminal lobe with the catalytic cysteine. A
ﬂexible hinge region between the N- and C-lobes bridges both por-
tions of the domain and enables the juxtapositioning of the cat-
alytic sites of E2 and E3 enzymes during ubiquitin shuttle [26].
Based on the domain architectures of their N-termini, which dic-
tate the speciﬁcity of ligase-substrate interactions, HECT type E3
enzymes are further subdivided into three families, i.e. Nedd4 fam-
ily, HERC family, and other HECT type ligases [27–29].
Growing number of recent studies have been concerned with
the role of E3 ubiquitin ligases in numerous cellular processes. In
this review, we focus on the role of HECT type E3 ubiquitin ligases
in nerve cell development and function, with a special emphasis on
neuritogenesis, polarity formation, and synaptic transmission, and
we discuss how their aberrant functioning contributes to human
brain pathophysiology.
2. HECT type ubiquitin ligases in neuronal polarity formation
and neuritogenesis
To execute their function in the streaming of information, neu-
rons require a precisely deﬁned polarization with well-deﬁned
input and output sites. Neuronal polarization begins when the
multipolar newborn neurons attach to radial glial cell processes
and acquire bipolar cell shapes. The neuronal polarization includes
asymmetrical distribution of polarity proteins, cytoskeletal compo-
nents, and cellular organelles into the future dendrites and axon
[30]. Stable microtubules in the main shaft and dynamic actin
remodeling at the growing tip underlie axon speciﬁcation and out-
growth [31]. In the neonatal brain, the Golgi apparatus extends
into the apical process of nascent pyramidal hippocampal neurons,
which later transforms into its dendritic tree. The polarized
deployment of Golgi structures is dependent on Reelin-Dab1 sig-
naling cascade, and this redistribution of the Golgi apparatus isknown to be critical for the development of dendrites and the axon
[32]. Neuritogenesis underlies the proper formation of neuronal
networks in the brain and allows for proper neuronal signal trans-
mission. It is controlled by a plethora of guidance cues that act
upon the growth cones of growing processes to further induce
cytoskeletal rearrangements, enabling neurite speciﬁcation and
extension through the brain milieu. Recent advances in ubiquitin
biology unravel undisputable roles of ubiquitylation in the control
of proteins that govern neuronal polarity formation and neurite
outgrowth [7].
Relatively recent ﬁndings document that E3 enzymes of HECT
type directly ubiquitylate small GTPases, which in turn regulates
their turnover, subcellular localization, or signaling in developing
neurons. Typically, small GTPases are active when GTP-bound
and inactive upon GTP hydrolysis to GDP. This ability to persis-
tently send a molecular signal when bound to GTP endows them
with a function as molecular switches. Small GTPases are potent
regulators of cytoskeleton remodeling, which among other pro-
cesses is critical for neuronal polarity acquisition, axonal guidance,
and neurite extension and branching [33,34].
2.1. The role of Nedd4 family E3 ubiquitin ligases in neuronal
development
Neural precursor cell expressed, developmentally downregu-
lated 4-1 (Nedd4-1) and SMAD ubiquitination regulatory factor 1
(Smurf1) belong to the Nedd4 subfamily of HECT type ubiquitin
ligases. Both proteins share a characteristic domain structure, with
an N-terminus composed of a calcium binding C2 domain and two
to four WW motives that bind proline-rich stretches in substrate
proteins. Such a domain organization indicates common activation
patterns, for example calcium-mediated membrane recruitment
[35]. Another important way of regulation of Nedd4 ligases is
phosphorylation. The afﬁnity of Smurf1 towards small GTPase
RhoA and Partitioning defective 6 (Par6) – a protein involved in cell
polarity formation – is strongly dependent upon its BDNF-induced
PKA-mediated phosphorylation. Phosphorylated Smurf1 loses
afﬁnity to Par6, thereby stabilizing it, and relocates to the tip of
the axon, where it polyubiquitylates RhoA and destines it for pro-
teasomal degradation. Overexpression of a phosphomimetic
mutant of Smurf1 in neurons causes formation of multiple axons,
whereas knock-down (KD) of Smurf1 or overexpression of a
phosphorylation-deﬁcient mutant leads to the inhibition of axon
acquisition (Fig. 1C and D). Taken together, these ﬁndings show
that phosphorylation of Smurf1 is critical for proper polarity for-
mation in neurons [36].
Recent data on the Nedd4 subfamily of HECT type Ubiquitin
Ligases demonstrate that their control over neuritogenesis does
not always involve proteasomal degradation of their substrates.
Nedd4-1 functions as a positive regulator of dendrite growth and
arborization. Monoubiquitlyation of the small GTPase Rap2 by
Nedd4-1 blocks the interaction of Rap2 with downstream target
proteins. In contrast to Smurf1 and Smurf2, which act on the inac-
tive, GDP-bound RhoA and Rap1B, Nedd4-1 monoubiquitylates
GTP-bound Rap2A and thereby abolishes the interaction with its
downstream effector protein TRAF2 and NCK-interacting protein
kinase (TNIK), which normally leads to neurite retraction
(Fig. 1A). Functional analyses of Nedd4-1 knock-out (KO) neurons
revealed decreased dendritic arbor complexity and dendrite exten-
sion (Fig. 1B). Overexpression of dominant-negative forms of either
Rap2 or TNIK rescues the effects of Nedd4-1 loss in neurons [37].
Interestingly, apart from its well-documented role in governing
dendritic tree complexity, Nedd4-1 has been reported to play a role
in axonal growth and branching of frog retinal ganglion cells and
mammalian peripheral nervous system neurons by ubiquitylating
Fig. 1. Regulation of dendritogenesis and neuronal polarity formation by Nedd4 family of HECT E3 ubiquitin ligases. (A) Model of neural precursor cell expressed,
developmentally downregulated (Nedd4-1) action in dendritogenesis. GTP-bound Rap2 is monoubiquitylated by Nedd4-1 following with the disruption of interaction
between Rap2 and its downstream effector protein TRAF2 and NCK-interacting protein kinase (TNIK). Active molecular complex of Rap2 and TNIK abrogates dendrite
outgrowth through TNIK-downstream proteins, whereas Nedd4-1-mediated Rap2 ubiquitylation promotes dendrite extension. (B) The scheme depicts a schematic
morphology of wild type and Nedd4-1 knock-out (KO) neurons. Note reduced dendritic tree complexity, axonal branching and shorter dendrites and axon in Nedd4-1 KO
nerve cell. (C) Model of Smurf1 action. GTP-bound RhoA activates its downstream effector proteins, e.g. RHO-associated protein kinase (ROCK). Once inactivated by its
GTPase-activating protein (GAP), RhoA is polyubiquitlyated by Smurf1 and consequently, degraded by proteasome. Local phosphorylation of Smurf1 at the axonal growth
cone and phosphorylation-dependent substrate switching of Smurf1 from Par6 to RhoA are critical for axon acquisition, allowing for Par6 stabilization at the dendrite and
leading to local degradation of RhoA at the axonal tip. (D) The scheme depicts schematic wild type and Smurf1 knock-down (KD) neurons. Note loss of neuronal polarity upon
Smurf1 KD. A and C modiﬁed after Kawabe, Brose [7].
M.C. Ambrozkiewicz, H. Kawabe / FEBS Letters 589 (2015) 1635–1643 1637phosphatase and tensin homologue (PTEN) and thus targeting it for
proteasomal degradation [38,39]. In the mammalian central ner-
vous system, loss of PTEN in the developing brain results in aber-
rant proliferation of neuronal precursors, deregulated neuronal
polarity acquisition, hypertrophy of neuronal somata, and exces-
sive neurite extension and branching. Conversely, overexpression
of PTEN in neurons leads to aberrances in axon speciﬁcation and
increased apoptosis, which is not congruent with phenotypic alter-
ations following Nedd4-1 and Nedd4-2 loss in nerve cells. Recent
functional analyses of murine Nedd4-1 and Nedd4-2 double KO
neurons revealed that both ligases facilitate axon growth of hip-
pocampal neurons without ubiquitylating PTEN. Contrary to previ-
ous data, it is PTEN that regulates Nedd4-1 expression at the
translational level by suppressing the mTORC1-PI3K pathway and
thereby limiting neurite outgrowth [40].
2.2. HUWE1 function in neuritogenesis and neuronal migration
In addition to the undisputable role of Nedd4 family members in
neuritogenesis and neuronal polarity formation described above,
other members of the HECT ligase family have been implicated in
shaping nerve cell morphology. Despite its well-documented role
in the control of neuronal differentiation and proliferation, HECT,UBA and WWE domain containing 1 (HUWE1) has emerged as an
important regulator of axonmorphology [41]. InDrosophilamelano-
gaster dorsal cluster neurons, the overexpression of HUWE1 leads to
an increase of axon terminal branching. The very elaborate molecu-
lar architecture of its N-terminus, composed of Armadillo
repeat-like domains, ubiquitin-associated domain UBA, WWE, and
BH3 domains, allows for speciﬁc ligase-substrate interactions. In
HUWE1 overexpressing neurons, aberrant axon terminal branching
may be attributable to disrupted Wnt/b-catenin signaling, because
of the reported reduction of Dishevelled – a molecule required for
Wnt signaling. Mutant ﬂies with lower doses of Dishevelled present
very similar phenotypic changes to those of HUWE1 overexpressing
ones with regard to axon architecture, which is partially rescued in
the ﬂies expressing a constitutively active variant of b-catenin [42].
Recentdata show thatHUWE1directlybindsDishevelled and conju-
gates it with Lys63-linked polyubiquitin chains. This prevents its
multimerization, which is critical for its function as a signal trans-
ducer [43]. Further experiments regarding morphological conse-
quences of HUWE1-mediated Dishevelled ubiquitylation in
neurons (e.g. overexpression of a ubiquitylation-deﬁcient mutant
of Dishevel led) would help to understand the involvement of the
ligase in the modulation of the Wnt pathway with respect to axon
branching. Interestingly, Nedd4-like and Itch – members of Nedd4
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Dishevelled and to thereby promote its consequent proteasomal
degradation [44,45].
As well as regulating axonal morphology, HUWE1 has been
described as an important regulator of nerve cell migration.
Deletion of HUWE1 from neuronal and glial progenitors follows
with dramatic morphological abnormalities in developing cerebel-
lum. HUWE1 has been previously shown to ubiquitylate N-Myc, a
protein crucial for cell proliferation. Down-regulation of N-Myc is
critical for termination of the cell cycle and differentiation of neu-
ronal progenitors [41]. In HUWE1 deﬁcient cerebellum, neuronal
precursors display enhanced levels of N-Myc, failure to exit cell
cycle, hyperproliferation and persistent ectopic nerve cell clusters.
Additionally, HUWE1 depletion results in severe delay in nerve cell
migration in developing cerebellum [46].
2.3. The function of E6AP/UBE3A in dendritogenesis
Ubiquitin ligase E6 associated protein (E6AP), also known as
ubiquitin ligase 3A (UBE3A) is the founding member of the HECT
type E3 ligase family. A great deal of research on UBE3A has been
performed in regard to synaptic transmission. In human and mur-
ine neurons, the paternal allele of Ube3a is silenced in the process
of genomic imprinting [47]. This silencing mainly involves a pater-
nally expressed cis-acting long non-coding antisense RNA that
competes with the sense Ube3a transcript. However, the molecular
fundaments of Ube3a imprinting remain to be conclusively deci-
phered [48]. In humans, loss-of-function mutations in the maternal
Ube3a allele cause Angelman syndrome (AS), a neurodevelopmen-
tal disorder characterized by severe intellectual disability, absent
speech, seizures, microcephaly, and movement disturbances [49–
53]. It has been reported that mutant ﬂies devoid of UBE3A exhibit
decreased dendritic branching of sensory neurons in the peripheral
nervous system. Moreover, dendritic arborization defects are also
present in ﬂies overexpressing Drosophila or a human version of
UBE3A, which indicates that a proper dose of the ligase is critical
for normal dendritogenesis [54]. The function of UBE3A in dendrite
development seems to be well conserved given that it is also indis-
pensable for polarized dendrite morphogenesis of murine cortical
and hippocampal CA1 pyramidal neurons. Interestingly, the loss
of UBE3A selectively inﬂuences apical dendrites, leaving the basal
processes unaffected. Knock-down of isoform 2 of UBE3A, but not
of isoforms 1 or 3, in vivo leads to growth arrest or a complete loss
of apical dendrites in developing neurons. Consequently, neurons
with lower levels of UBE3A isoform 2 display defects in
Reelin-induced polarization of the Golgi apparatus. Concomitant
analyses of a mouse model of Angelman syndrome with maternal
deﬁciency of Ube3a uncovered stunted and less branched apical
dendrites of cortical neurons layer II/III and neurons in the CA1
ﬁeld of hippocampus [55]. Moreover, pyramidal cells of
Angelman syndrome mice exhibit under-acidiﬁed Golgi vesicles
with swollen cisternae, and concomitant defective
Golgi-dependent protein sialylation [56]. Considering the devastat-
ing consequences of UBE3A loss, it will be important to study its
downstream ubiquitylation substrates involved in dendrite
development.
3. The role of HECT-type ubiquitin ligases in synaptic
transmission
After neuritogenesis, brain development advances to establish
the neural circuitry. Some HECT E3 ligases display a peak expres-
sion at that developmental stage and play critical roles in the reg-
ulation of synaptic transmission. In the central nervous system, the
majority of basal excitatory transmission is mediated byAMPA-type glutamate receptors (AMPARs) and kainate receptors
(KARs), whereas activation of the NMDA-type glutamate receptors
(NMDARs) allows for functional and structural synaptic plasticity
[57]. Excitatory synapses in the mammalian brain are mainly
located at the dendritic spines, which constitute the postsynaptic
compartments of glutamatergic neuronal synapses [58].
Neurotransmitter receptors are composed of subunits, and are
clustered and anchored at the synaptic specializations through
interactions between their intracellular domains and postsynaptic
scaffold proteins, such as postsynaptic density-95 (PSD-95), synap-
tic scaffolding molecule (S-SCAM), or glutamate receptor interact-
ing protein (GRIP). The dynamic regulation of the expression and
localization of synaptic proteins comprises the basis for synaptic
plasticity [59]. Apart from its canonical role in mediating proteaso-
mal degradation of its targets, ubiquitylation of transmembrane
proteins has recently emerged as a trigger for their internalization,
endocytosis, and endosomal sorting. Hence, by regulating the
abundance of surface receptors, ion channels or neurotransmitter
transporters, ubiquitylation plays a crucial role in the regulation
of synaptic transmission [60].
The ability of synapses to adjust their strength in response to
certain stimuli has long been proposed as a mechanism underlying
learning and memory. In the 1960s, Lomo brought ﬁrst experimen-
tal evidence showing that high frequency synaptic stimulation in
hippocampus can cause lasting increases in synaptic strength, a
phenomenon he termed long-term potentiation (LTP) [61]. In this
process, high frequency stimulation results in the release of the
magnesium block of NMDARs at the postsynaptic site, allowing
Ca2+ permeation. The resulting local increase in the postsynaptic
Ca2+ concentration activates two calcium dependent kinases, pro-
tein kinase C (PKC) and Ca2+/calmodulin kinase II (CaMKII), which
phosphorylate AMPARs and thereby increase AMPAR conductance
[62] and surface expression at the synapse [63]. Whereas the early
LTP phase (E-LTP) does not involve transcription or translation, the
late phase (L-LTP) requires new transcripts and de novo synthe-
sized proteins for the functional and structural remodeling of den-
dritic spines [64]. Recent evidence indicates that role of CaMKII in
LTP involves the local activation of small Rho-GTPases which are
responsible for morphological and physiological plasticity [65].
To date, LTP is the best-validated candidate molecular mechanism
of learning and memory [66].
One of the major ﬁndings proving that synapse function relies
on uncompromised ubiquitin signaling was the discovery that pro-
teasome inhibition completely abolishes LTP. Proteasome inhibi-
tion leads to stabilization of translational activators in dendritic
spines (such as eukaryotic initiation factor eIF4E and eukaryotic
elongation factor 1A eEF1A), resulting in augmentation of the early
phase of the LTP [67]. At later stages of L-LTP, proteasome inhibi-
tion leads to the accumulation of translational repressors (such
as polyadenylate-binding protein interacting protein 2, Paip2,
and eukaryotic initiation factor 4E-binding protein 2, 4E-BP2),
which disrupts L-LTP maintenance [68].
Although this particular ﬁeld of molecular neuroscience is still
underexplored, there are compelling experimental data concerning
physiological consequences of ubiquitylation of several synaptic
proteins, including PSD-95, GKAP, Shank, GRIP, and glutamate
receptors (mGluRs, AMPARs, NMDARs) [69]. In this section, we
only focus on the role of HECT type E3 ligases in regulating synap-
tic transmission.
3.1. The role of Nedd4 family HECT-type ubiquitin ligases in mature
neurons
As mentioned above, the depletion of the HECT type E3 ubiqui-
tin ligase Nedd4-1 in murine neurons leads to the formation of
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in synapse number and a reduction in synaptic transmission [37].
Concerning neuronal function, the members of Nedd4 family of
E3 enzymes are particularly interesting because of their
N-terminal C2 domain, thought to allow for the recruitment of
the ligases to lipid rafts in response to Ca2+ signals [35].
Nedd4-1 associates with all four AMPAR subunits (GluA1-4)
and ubiquitylates a C-terminal lysine cluster upon the application
of AMPAR agonists (i.e. AMPA) or GABAA receptor antagonists (i.e.
bicuculline). Lys-63-linked polyubiquitylation of GluA1 and GluA2
subunits requires the activation of voltage-gated calcium channels
and CamKII and leads to increased intracellular trafﬁcking and
endosomal sorting and degradation of AMPARs [70] (Fig. 2).
Consistently, overexpression of wild type Nedd4-1, but not of a cat-
alytically inactive mutant, results in a decrease in the amplitudes
of miniature excitatory postsynaptic currents (mEPSCs) and in an
increase in the ratio of NMDAR-mediated versus AMPAR-
mediated transmission, which is indicative of a decrease in synap-
tic AMPAR levels [71]. The C2 domain of Nedd4-1 facilitates bind-
ing of the ligase to GluA1-containing AMPARs. Nedd4-1 mutants
lacking the N-terminal C2 domain fail to reduce synaptic transmis-
sion and AMPAR surface expression. Moreover, wild type Nedd4-1,
but not a mutant lacking the C2 domain, undergoes rapid
Ca2+-dependent relocalization into dendritic spines of hippocam-
pal neurons upon AMPAR activation [72].
Another piece of evidence indicating a fundamental role of
Nedd4-1 in synaptic transmission comes from studies on the effect
of stress on cognition in rats. Animals exposed to stress perform
worse in recognition memory tasks, which involve the prefrontal
cortex (PFC). After stress, there is a decrease in surface levels of
AMPARs and NMDARs in PFC pyramidal neurons and a concomi-
tant reduction of glutamate-evoked synaptic transmission in the
PFC. Those stress-induced homeostatic adjustments are attributa-
ble to the action of glucocorticoids released during chronic stress.
Serum- and glucocorticoid regulated kinase 1 (SGK1) phosphory-
lates Nedd4-1 and enhances Nedd4-1-mediated increase inFig. 2. Nedd4-1 controls synaptic transmission. CamKII and Sgk1 induce Nedd4-1 to
mediates the recruitment of the ligase to the neuronal membrane. AMPARs ubiquitylation
then either recycled back to the neuronal plasma membrane through the recycling endoGluA1 ubiquitylation. Hence, stress is followed by excessive degra-
dation of AMPARs and NMDARs in the rat PFC. KD of Nedd4-1 and
inhibition of the proteasome, but not lysosomal blockers, rescue
glutamatergic responses in rat PFC pyramidal neurons and recogni-
tion memory in stressed rats. Taken together, Nedd4-1 has
emerged as an important regulator of neuronal homeostasis and
synaptic plasticity in the mammalian brain, where it acts by ubiq-
uitylating glutamate receptors, leading to their degradation [73]
(Fig. 2).
Apart from their regulatory effects on neurotransmitter recep-
tors, there is substantial experimental evidence for in vitro as well
as in vivo involvement of Nedd4 family E3 ligases in the regulation
of ion channel density at the plasma membrane. Nedd4 ligases rec-
ognize PY motives of intracellular portions of voltage-gated
sodium (Nav), potassium (Kv) and calcium (Cav) channels.
Nedd4-1 overexpression reduces the number of Cav1.2 channels
inserted into the plasma membrane, facilitating its proteasomal
degradation and lysosomal sorting [74]. Moreover, Nedd4-2 has
also been reported to ubiquitylate Kv7.1 and thus to regulate the
channel dynamics at the plasma membrane affecting potassium
homeostasis in cells [75]. In addition, Nedd4-2 has been found to
hamper the activity of Nav1.2, Nav1.7 and Nav1.8 in Xenopus
oocytes [76]. Interestingly, recent data demonstrate that Nedd4-2
regulates plasma membrane expression of Navs in murine primary
cortical neurons in response to the increase of intracellular Na+
[77].
Murine Nedd4-2 plays a critical role in regulating neuropathic
pain, a condition resultant from aberrances in voltage-gated
sodium channel function. In mice, sciatic nerve injury decreases
the level of Nedd4-2 in dorsal root ganglion (DRG) neurons, with
a concomitant subcellular relocalization of Nav1.7 and an increase
in the amplitude of Nav1.7 and Nav1.8 currents. Interestingly, ani-
mals with selective Nedd4-2 KO in DRG neurons exhibit increased
thermal hypersensitivity and allodynia – a condition where a stim-
ulus that normally does not elicit pain provokes a pain response.
Both, the pathological conditions and the augmented Nav currentubiquitylate GluA1-containing AMPARs. Calcium binding C2 domain of Nedd4-1
promotes their intracellular trafﬁcking and endosomal sorting. The receptors can be
some or trafﬁcked to the late endosome and degraded.
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by viral delivery of Nedd4-2 to DRG neurons [78]. Additionally,
Nedd4-2-mediated ubiquitylation of neurotrophin receptor TrkA
has been linked to neuronal survival and pain sensitivity. Mutant
of TrkA harboring a point mutation P782S that hampers its binding
to Nedd4-2 displays decreased ubiquitylation in response to nerve
growth factor (NGF), impaired degradation and altered endosomal
sorting. Consequently, TrkAP782S knock-in mice exhibit increased
number of DRG neurons that transmit nociceptive stimuli and pre-
sent hypersensitivity to thermal and inﬂammatory pain [79].
Not only does the ubiquitylation by Nedd4 family E3 ligases
inﬂuence the function of neurotransmitter receptors and ion chan-
nels, but it also governs neuronal homeostasis by controlling the
surface levels of dopamine transporters (DATs). Brain dopamine
is active in several systems, which operate in reward-motivated
behavior and motor control. DATs, which transport dopamine from
the extracellular space into dopaminergic neurons and thereby
reduce dopamine signaling, are potent targets of psychoactive
drugs, like cocaine and amphetamine. Nedd4-2 was found to asso-
ciate with DATs in rat striatum and to mediate their protein kinase
C-induced ubiquitylation [80], which seems to be critical for DAT
endocytosis and endosomal sorting [81]. Moreover, the ligase reg-
ulates the reuptake of glutamate by reducing surface expression of
excitatory amino acid transporter 2 (EAAT2), the most abundant
glutamate carrier in the mammalian central nervous system [82].
Altogether, Nedd4-2 modiﬁes molecules of crucial importance for
nerve cell function and homeostasis by affecting their subcellular
localization and by modulating their activity.
3.2. E6AP/UBE3A and the molecular basis of Angelman syndrome
Among the HECT type ligases, E6AP/UBE3A has been most
extensively studied in regard to synaptic transmission. As summa-
rized above, maternal deﬁciency of UBE3A is a cause of Angelman
syndrome in humans, and a substantial number of studies on
Ube3a KO mice have contributed to our present understanding of
the molecular pathologies behind this disease.
In the mammalian nervous system, the maternal allele drives
the expression of Ube3a in hippocampal and cerebellar neurons.
Early genetic studies revealed that mice lacking maternal Ube3a
recapitulate phenotypic traits of Angelman syndrome patients,
including seizures, behavioral deﬁcits in motor function, and aber-
rances in spatial and contextual learning [83,84]. Interestingly,
Ube3a KO mice exhibit abnormal hippocampal electroencephalo-
grams with spikes, sharp waves, and spike-wave discharges [83].
In maternal UBE3A-deﬁcient animals, LTP measurements in the
CA1 subﬁeld of hippocampus uncovered very transient potentia-
tion as compared to controls. The molecular basis of impaired
LTP in mice deﬁcient of maternal Ube3a has been attributed to
the increased phosphorylation of CaMKII, its lower activity, and
decreased levels of CaMKII associated with postsynaptic sites [85].
Although hippocampal and cerebellar gross morphology and
cellular organization seem to be unaffected by UBE3A loss, there
are electron microscopy data on mitochondrial dysfunction and
their defective morphology in CA1 hippocampal neurons of
Ube3a-deﬁcient mice [86]. Moreover, UBE3A has been found to
localize to the pre- and postsynaptic compartments of hippocam-
pal neurons and to affect spine morphology of cerebellar Purkinje
cells and hippocampal pyramidal cells [87].
Additional work focusing on the function of UBE3A indicates
that changes in synaptic transmission in neurons devoid of Ube3a
are attributable to synaptic dysfunction. A recent study uncovered
that Ube3a loss in visual cortex results in impairment of LTP and
long-term depression (LTD) – the latter representing an activity
dependent reduction in synaptic strength. Further,Ube3a-deﬁcient layer II/III pyramidal cells of the visual cortex exhi-
bit a loss of dendritic spines. Strikingly, UBE3A-mediated loss of
plasticity seems to be dependent on visual inputs because defects
in LTP and morphological disturbances are only present in animals
that have been exposed to light and not in mice reared in complete
darkness. Thus, apart from its evident role in hippocampal plastic-
ity, UBE3A has a major function in sensory stimulus-dependent
development of neuronal circuits in the neocortex [88].
A great deal of work has been performed with respect to the
identiﬁcation of functionally relevant UBE3A substrates. At the cel-
lular level, UBE3A depletion leads to an increase in the expression
of activity-regulated cytoskeleton-associated protein (Arc), a
synaptic molecule that promotes endocytosis of AMPARs at excita-
tory synapses. Consequently, KO of Ube3a results in a reduction of
mEPSCs frequency attributable to a decrease in available synaptic
spines. Delivery of shRNA hairpins against Arc to neurons devoid
of UBE3A restores AMPAR-positive synapses [89]. Recombinant
Arc is ubiquitylated by UBE3A in in vitro ubiquitylation assays.
However, if Arc is indeed a substrate for UBE3A still remains con-
troversial. Instead, recent ﬁndings indicate transcriptional regula-
tion of Arc by UBE3A [90]. Other experiments uncover that
increased Arc association with PSD95 in Ube3a-deﬁcient mice is a
consequence of aberrant TrkB signaling [91].
Further identiﬁed UBE3A substrates include Ephexin5 (E5), a
RhoA guanine nucleotide exchange factor (GEF). Overexpression
of E5 in rat hippocampal neurons leads to a reduction of the num-
ber of dendritic spines, and the ability of E5 to regulate spine for-
mation depends on its GEF activity. UBE3A binds to phospho
rylated E5 and mediates its proteasomal degradation.
Consequently, the level of E5 is signiﬁcantly higher in maternal
Ube3a KO mouse brain than in controls, which may explain the
aberrances in spine morphology of Ube3a-deﬁcient neurons [92].
Taken together, UBE3A has emerged as a crucial molecular deter-
minant of proper synaptic transmission (Fig. 3).
4. Ubiquitin signaling in the brain disease
Disturbances of ubiquitin signaling underlie a plethora of
human brain diseases (Table 1). Interestingly, mutations in genes
encoding HECT type E3 ligases and DUBs have been characterized
in patients with intellectual disability, including X-linked mental
retardation syndromes. Huwe1, encoded on the X chromosome, is
mutated in patients with Brooks–Wisniewski–Brown syndrome
[93,94]. The analysis of a brain speciﬁc Huwe1 KO uncovered
defects in neurogenesis, which may be at the basis of the pathology
[41,95]. Importantly, dysfunction of deubiquitylating enzymes are
also deleterious for brain function. Usp9x is a DUB found to protect
Itch [96] and Smurf1 [97] from auto-ubiquitylation and resultant
degradation, and mutations in the gene encoding for this DUB
are associated with X-linked mental retardation [98].
Protein ubiquitylation and ubiquitin signaling have been also
implicated in neuroprotection following stroke. Interestingly,
ligases of Nedd4 subfamily and adaptor protein Nedd4 family
interacting protein 1 (Ndﬁp1) are induced following ischemic
insult in rats. Furthermore, after focal cerebral ischemia, Ndﬁp1
and Nedd4-2 are up-regulated in cortical neurons resistant to the
insult. However, if this alteration correlates with putative neuro-
protective properties of both proteins, remains to be elucidated
[99].
Ubiquitin ligase E3B and E3C (UBE3B and UBE3C) form a sepa-
rate subfamily of HECT type enzymes due to their unique domain
organization. Both ligases posses a single N-terminal IQ motif,
which is thought to bind calmodulin [100], and a HECT domain
of a distinct architecture. The homology between the catalytic
domain of UBE3B and UBE3C is higher than when compared to
Fig. 3. UBE3A in the regulation of spinogenesis. (A) In wild type mice, UBE3A binds to and mediates ubiquitylation of Ephexin5 (E5) leading to its proteasomal degradation. E5
functions as RhoA guanine nucleotide exchange factor (GEF), facilitating the switch from its inactive to active GTP-bound form. UBE3A-mediated E5 degradation inactivates
RhoA and allows for dendritic spine formation. (B) In the Ube3a-deﬁcient mice, a model of Angelman syndrome, loss of UBE3A follows with loss of ubiquitylation and an
increase in the protein level of E5, which leads to an enhanced RhoA activity and perturbs growth and maturation of spines. Another downstream of UBE3A – Arc, mediates
removal of glutamate receptors from dendritic spines in Ube3a-deﬁcient mice. Note shorter spines in Ube3a-deﬁcient neurons. Modiﬁed after Scheiffele, Beg, 2010 [110].
Table 1
HECT type E3 ligases in human brain disease. Loss of function or point mutations of E3
ligase genes depicted in the left column have been reported in human developmental
disorders listed in the middle column.
Ligase Disease References
HUWE1 Brooks–Wisniewski–Brown
syndrome
Brooks et al. [93]
X-linked mental retardation Froyen et al. [94]
UBE3A Angelman syndrome Kishino et al. [52]
Malcolm et al. [50]
Knoll et al. [51]
UBE3B Kaufman oculocerebrofacial
syndrome
Basel-Vanagaite et al.
[101]
Flex et al. [103]
Pedurupillay et al. [104]
Basel-Vanagaite et al.
[102]
Autism Spectrum Disorder Chahrour et al. [105]
UBE3C Autism Spectrum Disorder O’Roak et al. [107]
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HECT type E3 ligases. Interestingly, truncating loss-of-function
mutations in human UBE3B have been recently characterized in
patients suffering from Kaufman Oculocerebrofacial Syndrome.
Neurological features of the disease encompass hypoplasia of cor-
pus callosum, reduced pituitary size, Chiari Type I malformation,
and severe intellectual disability [101–104]. Moreover, genetic
screening of patients diagnosed with familial autism reveals point
mutations in the catalytic domain of UBE3B [105]. Strikingly, the
homolog of UBE3B, UBE3C has been found to associate with human
postsynaptic densities [106], and a point mutation in its HECT
domain has been described in patients with sporadic autism[107]. Future work should decipher the involvement of UBE3B
and UBE3C in neuronal function.
5. Conclusions and perspectives
The omnipresence of ubiquitin and ubiquitylation processes
makes the study of its biochemistry very complex and intricately
tangled. There is compelling evidence that research on protein
ubiquitylation on the cellular and biochemical level in neurons
leads to a better understanding of the molecular basis of human
diseases.
The restoration of the function of HECT type E3 ligases holds a
signiﬁcant therapeutic potential. A recent report indicated that
delivery of antisense oligonucleotides reduces the silencing of
paternal Ube3a expression in the mouse model of AS with maternal
deﬁciency for Ube3a. The treatment ameliorated some phenotypic
traits of AS and improved cognitive performance of affected ani-
mals [108]. HECT type ligases also emerged as potent targets for
small molecules that affect their enzymatic activity, which offers
possible pharmaceutical applications [109].
Looking closer at the cellular and molecular function of E3 ubiq-
uitin ligases will therefore provide new insights into pathology and
bring new curative prospects for autism, intellectual disability syn-
dromes, neuropathic pain, neurodegeneration, or brain ischemia.
Acknowledgments
We would like to thank Nils Brose for his helpful comments on
the manuscript. Work in our own laboratory has been supported
by the German Research Foundation (SPP1365/KA3423/1-1; to
H.K.) and the Fritz Thyssen Foundation (to H.K.).
1642 M.C. Ambrozkiewicz, H. Kawabe / FEBS Letters 589 (2015) 1635–1643References
[1] Lange, W. (1975) Cell number and cell density in the cerebellar cortex of man
and some other mammals. Cell Tissue Res. 157, 115–124.
[2] Shariff, G.A. (1953) Cell counts in the primate cerebral cortex. J. Comp.
Neurol. 98, 381–400.
[3] Zeilhofer, H.U., Wildner, H. and Yevenes, G.E. (2012) Fast synaptic inhibition
in spinal sensory processing and pain control. Physiol. Rev. 92, 193–235.
[4] Gaier, E.D., Rodriguiz, R.M., Ma, X.M., Sivaramakrishnan, S., Bousquet-Moore,
D., Wetsel, W.C., Eipper, B.A. and Mains, R.E. (2010) Haploinsufﬁciency in
peptidylglycine alpha-amidating monooxygenase leads to altered synaptic
transmission in the amygdala and impaired emotional responses. J. Neurosci.
30, 13656–13669.
[5] Spruston, N. (2008) Pyramidal neurons: dendritic structure and synaptic
integration. Nat. Rev. Neurosci. 9, 206–221.
[6] Lewis Jr., T.L., Courchet, J. and Polleux, F. (2013) Cell biology in neuroscience:
cellular and molecular mechanisms underlying axon formation, growth, and
branching. J. Cell Biol. 202, 837–848.
[7] Kawabe, H. and Brose, N. (2011) The role of ubiquitylation in nerve cell
development. Nat. Rev. Neurosci. 12, 251–268.
[8] Funahashi, Y., Namba, T., Nakamuta, S. and Kaibuchi, K. (2014) Neuronal
polarization in vivo: growing in a complex environment. Curr. Opin.
Neurobiol. 27, 215–223.
[9] Hershko, A., Heller, H., Elias, S. and Ciechanover, A. (1983) Components of
ubiquitin-protein ligase system. Resolution, afﬁnity puriﬁcation, and role in
protein breakdown. J. Biol. Chem. 258, 8206–8214.
[10] Ciechanover, A., Elias, S., Heller, H. and Hershko, A. (1982) ‘‘Covalent afﬁnity’’
puriﬁcation of ubiquitin-activating enzyme. J. Biol. Chem. 257, 2537–2542.
[11] Hershko, A., Leshinsky, E., Ganoth, D. and Heller, H. (1984) ATP-dependent
degradation of ubiquitin-protein conjugates. Proc. Natl. Acad. Sci. U.S.A. 81,
1619–1623.
[12] Baumeister, W., Walz, J., Zuhl, F. and Seemuller, E. (1998) The proteasome:
paradigm of a self-compartmentalizing protease. Cell 92, 367–380.
[13] Pickart, C.M. and Cohen, R.E. (2004) Proteasomes and their kin: proteases in
the machine age. Nat. Rev. Mol. Cell Biol. 5, 177–187.
[14] Rechsteiner, M. and Hill, C.P. (2005) Mobilizing the proteolytic machine: cell
biological roles of proteasome activators and inhibitors. Trends Cell Biol. 15,
27–33.
[15] Amerik, A.Y. and Hochstrasser, M. (2004) Mechanism and function of
deubiquitinating enzymes. Biochim. Biophys. Acta 1695, 189–207.
[16] Chau, V., Tobias, J.W., Bachmair, A., Marriott, D., Ecker, D.J., Gonda, D.K. and
Varshavsky, A. (1989) A multiubiquitin chain is conﬁned to speciﬁc lysine in
a targeted short-lived protein. Science 243, 1576–1583.
[17] Ciechanover, A., Finley, D. and Varshavsky, A. (1984) Ubiquitin dependence of
selective protein degradation demonstrated in the mammalian cell cycle
mutant ts85. Cell 37, 57–66.
[18] Xu, P. et al. (2009) Quantitative proteomics reveals the function of
unconventional ubiquitin chains in proteasomal degradation. Cell 137,
133–145.
[19] Na, C.H., Jones, D.R., Yang, Y., Wang, X., Xu, Y. and Peng, J. (2012) Synaptic
protein ubiquitination in rat brain revealed by antibody-based ubiquitome
analysis. J. Proteome Res. 11, 4722–4732.
[20] Goh, L.K. and Sorkin, A. (2013) Endocytosis of receptor tyrosine kinases. Cold
Spring Harb. Perspect. Biol. 5, a017459.
[21] Hicke, L. and Riezman, H. (1996) Ubiquitination of a yeast plasma membrane
receptor signals its ligand-stimulated endocytosis. Cell 84, 277–287.
[22] Locke, M., Toth, J.I. and Petroski, M.D. (2014) Lys11- and Lys48-linked
ubiquitin chains interact with p97 during endoplasmic-reticulum-associated
degradation. Biochem J 459, 205–216.
[23] Huibregtse, J.M., Scheffner, M., Beaudenon, S. and Howley, P.M. (1995) A
family of proteins structurally and functionally related to the E6-AP
ubiquitin–protein ligase. Proc. Natl. Acad. Sci. U.S.A. 92, 2563–2567.
[24] Lorick, K.L., Jensen, J.P., Fang, S., Ong, A.M., Hatakeyama, S. and Weissman,
A.M. (1999) RING ﬁngers mediate ubiquitin-conjugating enzyme (E2)-
dependent ubiquitination. Proc. Natl. Acad. Sci. U.S.A. 96, 11364–11369.
[25] Barlow, P.N., Luisi, B., Milner, A., Elliott, M. and Everett, R. (1994) Structure of
the C3HC4 domain by 1H-nuclear magnetic resonance spectroscopy. A new
structural class of zinc-ﬁnger. J. Mol. Biol. 237, 201–211.
[26] Maspero, E., Mari, S., Valentini, E., Musacchio, A., Fish, A., Pasqualato, S. and
Polo, S. (2011) Structure of the HECT:ubiquitin complex and its role in
ubiquitin chain elongation. EMBO Rep. 12, 342–349.
[27] Rotin, D. and Kumar, S. (2009) Physiological functions of the HECT family of
ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 10, 398–409.
[28] Kumar, S., Harvey, K.F., Kinoshita, M., Copeland, N.G., Noda, M. and Jenkins,
N.A. (1997) CDNA cloning, expression analysis, and mapping of the mouse
Nedd4 gene. Genomics 40, 435–443.
[29] Hochrainer, K., Mayer, H., Baranyi, U., Binder, B., Lipp, J. and Kroismayr, R.
(2005) The human HERC family of ubiquitin ligases: novel members,
genomic organization, expression proﬁling, and evolutionary aspects.
Genomics 85, 153–164.
[30] Polleux, F. and Snider, W. (2010) Initiating and growing an axon. Cold Spring
Harb. Perspect. Biol. 2, a001925.
[31] Witte, H., Neukirchen, D. and Bradke, F. (2008) Microtubule stabilization
speciﬁes initial neuronal polarization. J. Cell Biol. 180, 619–632.[32] Matsuki, T., Matthews, R.T., Cooper, J.A., van der Brug, M.P., Cookson, M.R.,
Hardy, J.A., Olson, E.C. and Howell, B.W. (2010) Reelin and stk25 have
opposing roles in neuronal polarization and dendritic Golgi deployment. Cell
143, 826–836.
[33] Gonzalez-Billault, C., Munoz-Llancao, P., Henriquez, D.R., Wojnacki, J., Conde,
C. and Caceres, A. (2012) The role of small GTPases in neuronal
morphogenesis and polarity. Cytoskeleton (Hoboken) 69, 464–485.
[34] Conde, C. and Caceres, A. (2009) Microtubule assembly, organization and
dynamics in axons and dendrites. Nat. Rev. Neurosci. 10, 319–332.
[35] Scott, A.M., Antal, C.E. and Newton, A.C. (2013) Electrostatic and hydrophobic
interactions differentially tune membrane binding kinetics of the C2 domain
of protein kinase Calpha. J. Biol. Chem. 288, 16905–16915.
[36] Cheng, P.L., Lu, H., Shelly, M., Gao, H. and Poo, M.M. (2011) Phosphorylation of
E3 ligase Smurf1 switches its substrate preference in support of axon
development. Neuron 69, 231–243.
[37] Kawabe, H. et al. (2010) Regulation of Rap2A by the ubiquitin ligase Nedd4-1
controls neurite development. Neuron 65, 358–372.
[38] Drinjakovic, J., Jung, H., Campbell, D.S., Strochlic, L., Dwivedy, A. and Holt, C.E.
(2010) E3 ligase Nedd4 promotes axon branching by downregulating PTEN.
Neuron 65, 341–357.
[39] Christie, K.J., Martinez, J.A. and Zochodne, D.W. (2012) Disruption of E3 ligase
NEDD4 in peripheral neurons interrupts axon outgrowth: Linkage to PTEN.
Mol. Cell. Neurosci. 50, 179–192.
[40] Hsia, H.E. et al. (2014) Ubiquitin E3 ligase Nedd4-1 acts as a downstream
target of PI3K/PTEN-mTORC1 signaling to promote neurite growth. Proc.
Natl. Acad. Sci. U.S.A. 111, 13205–13210.
[41] Zhao, X., Heng, J.I., Guardavaccaro, D., Jiang, R., Pagano, M., Guillemot, F.,
Iavarone, A. and Lasorella, A. (2008) The HECT-domain ubiquitin ligase
Huwe1 controls neural differentiation and proliferation by destabilizing the
N-Myc oncoprotein. Nat. Cell Biol. 10, 643–653.
[42] Vandewalle, J. et al. (2013) Ubiquitin ligase HUWE1 regulates axon branching
through theWnt/beta-catenin pathway in a Drosophila model for intellectual
disability. PLoS ONE 8, e81791.
[43] de Groot, R.E. et al. (2014) Huwe1-mediated ubiquitylation of dishevelled
deﬁnes a negative feedback loop in the Wnt signaling pathway. Sci. Signal. 7,
ra26.
[44] Ding, Y., Zhang, Y., Xu, C., Tao, Q.H. and Chen, Y.G. (2013) HECT domain-
containing E3 ubiquitin ligase NEDD4L negatively regulates Wnt signaling by
targeting dishevelled for proteasomal degradation. J. Biol. Chem. 288, 8289–
8298.
[45] Wei, W., Li, M., Wang, J., Nie, F. and Li, L. (2012) The E3 ubiquitin ligase ITCH
negatively regulates canonical Wnt signaling by targeting dishevelled
protein. Mol. Cell. Biol. 32, 3903–3912.
[46] D’Arca, D., Zhao, X., Xu, W., Ramirez-Martinez, N.C., Iavarone, A. and Lasorella,
A. (2010) Huwe1 ubiquitin ligase is essential to synchronize neuronal and
glial differentiation in the developing cerebellum. Proc. Natl. Acad. Sci. U.S.A.
107, 5875–5880.
[47] Rougeulle, C., Glatt, H. and Lalande, M. (1997) The Angelman syndrome
candidate gene, UBE3A/E6-AP, is imprinted in brain. Nat. Genet. 17, 14–15.
[48] Chamberlain, S.J. and Brannan, C.I. (2001) The Prader–Willi syndrome
imprinting center activates the paternally expressed murine Ube3a
antisense transcript but represses paternal Ube3a. Genomics 73, 316–322.
[49] Steffenburg, S., Gillberg, C.L., Steffenburg, U. and Kyllerman, M. (1996)
Autism in Angelman syndrome: a population-based study. Pediatr. Neurol.
14, 131–136.
[50] Malcolm, S., Clayton-Smith, J., Nichols, M., Robb, S., Webb, T., Armour, J.A.,
Jeffreys, A.J. and Pembrey, M.E. (1991) Uniparental paternal disomy in
Angelman’s syndrome. Lancet 337, 694–697.
[51] Knoll, J.H., Nicholls, R.D., Magenis, R.E., Graham Jr., J.M., Lalande, M. and Latt,
S.A. (1989) Angelman and Prader–Willi syndromes share a common
chromosome 15 deletion but differ in parental origin of the deletion. Am. J.
Med. Genet. 32, 285–290.
[52] Kishino, T., Lalande, M. and Wagstaff, J. (1997) UBE3A/E6-AP mutations cause
Angelman syndrome. Nat. Genet. 15, 70–73.
[53] Matsuura, T., Sutcliffe, J.S., Fang, P., Galjaard, R.J., Jiang, Y.H., Benton, C.S.,
Rommens, J.M. and Beaudet, A.L. (1997) De novo truncating mutations in E6-
AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat. Genet.
15, 74–77.
[54] Lu, Y., Wang, F., Li, Y., Ferris, J., Lee, J.A. and Gao, F.B. (2009) The Drosophila
homologue of the Angelman syndrome ubiquitin ligase regulates the
formation of terminal dendritic branches. Hum. Mol. Genet. 18, 454–462.
[55] Miao, S., Chen, R., Ye, J., Tan, G.H., Li, S., Zhang, J., Jiang, Y.H. and Xiong, Z.Q.
(2013) The Angelman syndrome protein Ube3a is required for polarized
dendrite morphogenesis in pyramidal neurons. J. Neurosci. 33, 327–333.
[56] Condon, K.H., Ho, J., Robinson, C.G., Hanus, C. and Ehlers, M.D. (2013) The
Angelman syndrome protein Ube3a/E6AP is required for Golgi acidiﬁcation
and surface protein sialylation. J. Neurosci. 33, 3799–3814.
[57] Lu, W., Man, H., Ju, W., Trimble, W.S., MacDonald, J.F. and Wang, Y.T. (2001)
Activation of synaptic NMDA receptors induces membrane insertion of new
AMPA receptors and LTP in cultured hippocampal neurons. Neuron 29, 243–
254.
[58] Bourne, J.N. and Harris, K.M. (2008) Balancing structure and function at
hippocampal dendritic spines. Annu. Rev. Neurosci. 31, 47–67.
[59] Shepherd, J.D. and Huganir, R.L. (2007) The cell biology of synaptic plasticity:
AMPA receptor trafﬁcking. Annu. Rev. Cell Dev. Biol. 23, 613–643.
M.C. Ambrozkiewicz, H. Kawabe / FEBS Letters 589 (2015) 1635–1643 1643[60] Pavlopoulos, E., Triﬁlieff, P., Chevaleyre, V., Fioriti, L., Zairis, S., Pagano, A.,
Malleret, G. and Kandel, E.R. (2011) Neuralized1 activates CPEB3: a function
for nonproteolytic ubiquitin in synaptic plasticity and memory storage. Cell
147, 1369–1383.
[61] Lomo, T. (2003) The discovery of long-term potentiation. Philos. Trans. R. Soc.
Lond. B Biol. Sci. 358, 617–620.
[62] Jenkins, M.A. and Traynelis, S.F. (2012) PKC phosphorylates GluA1-Ser831 to
enhance AMPA receptor conductance. Channels (Austin) 6, 60–64.
[63] He, K., Goel, A., Ciarkowski, C.E., Song, L. and Lee, H.K. (2011) Brain area
speciﬁc regulation of synaptic AMPA receptors by phosphorylation. Commun.
Integr. Biol. 4, 569–572.
[64] Frey, U., Frey, S., Schollmeier, F. and Krug, M. (1996) Inﬂuence of actinomycin
D, a RNA synthesis inhibitor, on long-term potentiation in rat hippocampal
neurons in vivo and in vitro. J. Physiol. 490 (Pt 3), 703–711.
[65] Murakoshi, H., Wang, H. and Yasuda, R. (2011) Local, persistent activation of
Rho GTPases during plasticity of single dendritic spines. Nature 472, 100–
104.
[66] Nabavi, S., Fox, R., Proulx, C.D., Lin, J.Y., Tsien, R.Y. and Malinow, R. (2014)
Engineering a memory with LTD and LTP. Nature 511, 348–352.
[67] Dong, C., Upadhya, S.C., Ding, L., Smith, T.K. and Hegde, A.N. (2008)
Proteasome inhibition enhances the induction and impairs the
maintenance of late-phase long-term potentiation. Learn. Mem. 15, 335–347.
[68] Dong, C., Bach, S.V., Haynes, K.A. and Hegde, A.N. (2014) Proteasome
modulates positive and negative translational regulators in long-term
synaptic plasticity. J. Neurosci. 34, 3171–3182.
[69] Lin, A.W. and Man, H.Y. (2013) Ubiquitination of neurotransmitter receptors
and postsynaptic scaffolding proteins. Neural Plast. 2013, 432057.
[70] Widagdo, J., Chai, Y.J., Ridder, M.C., Chau, Y.Q., Johnson, R.C., Sah, P., Huganir,
R.L. and Anggono, V. (2015) Activity-dependent ubiquitination of GluA1 and
GluA2 regulates AMPA receptor intracellular sorting and degradation. Cell
Rep..
[71] Schwarz, L.A., Hall, B.J. and Patrick, G.N. (2010) Activity-dependent
ubiquitination of GluA1 mediates a distinct AMPA receptor endocytosis and
sorting pathway. J. Neurosci. 30, 16718–16729.
[72] Scudder, S.L., Goo, M.S., Cartier, A.E., Molteni, A., Schwarz, L.A., Wright, R. and
Patrick, G.N. (2014) Synaptic strength is bidirectionally controlled by
opposing activity-dependent regulation of Nedd4-1 and USP8. J. Neurosci.
34, 16637–16649.
[73] Yuen, E.Y., Wei, J., Liu, W., Zhong, P., Li, X. and Yan, Z. (2012) Repeated stress
causes cognitive impairment by suppressing glutamate receptor expression
and function in prefrontal cortex. Neuron 73, 962–977.
[74] Rougier, J.S., Albesa, M., Abriel, H. and Viard, P. (2011) Neuronal precursor
cell-expressed developmentally down-regulated 4–1 (NEDD4-1) controls the
sorting of newly synthesized Ca(V)1.2 calcium channels. J. Biol. Chem. 286,
8829–8838.
[75] Andersen, M.N., Krzystanek, K., Jespersen, T., Olesen, S.P. and Rasmussen, H.B.
(2012) AMP-activated protein kinase downregulates Kv7.1 cell surface
expression. Trafﬁc 13, 143–156.
[76] Rougier, J.S. et al. (2005) Molecular determinants of voltage-gated sodium
channel regulation by the Nedd4/Nedd4-like proteins. Am. J. Physiol. Cell
Physiol. 288, C692–C701.
[77] Ekberg, J.A., Boase, N.A., Rychkov, G., Manning, J., Poronnik, P. and Kumar, S.
(2014) Nedd4-2 (NEDD4L) controls intracellular Na(+)-mediated activity of
voltage-gated sodium channels in primary cortical neurons. Biochem. J. 457,
27–31.
[78] Laedermann, C.J. et al. (2013) Dysregulation of voltage-gated sodium
channels by ubiquitin ligase NEDD4-2 in neuropathic pain. J. Clin. Invest.
123, 3002–3013.
[79] Yu, T. et al. (2014) In vivo regulation of NGF-mediated functions by Nedd4-2
ubiquitination of TrkA. J. Neurosci. 34, 6098–6106.
[80] Sorkina, T., Miranda, M., Dionne, K.R., Hoover, B.R., Zahniser, N.R. and Sorkin,
A. (2006) RNA interference screen reveals an essential role of Nedd4-2 in
dopamine transporter ubiquitination and endocytosis. J. Neurosci. 26, 8195–
8205.
[81] Vina-Vilaseca, A. and Sorkin, A. (2010) Lysine 63-linked polyubiquitination of
the dopamine transporter requires WW3 and WW4 domains of Nedd4-2 and
UBE2D ubiquitin-conjugating enzymes. J. Biol. Chem. 285, 7645–7656.
[82] Boehmer, C., Palmada, M., Rajamanickam, J., Schniepp, R., Amara, S. and Lang,
F. (2006) Post-translational regulation of EAAT2 function by co-expressed
ubiquitin ligase Nedd4-2 is impacted by SGK kinases. J. Neurochem. 97, 911–
921.
[83] Miura, K., Kishino, T., Li, E., Webber, H., Dikkes, P., Holmes, G.L. and Wagstaff,
J. (2002) Neurobehavioral and electroencephalographic abnormalities in
Ube3a maternal-deﬁcient mice. Neurobiol. Dis. 9, 149–159.
[84] Jiang, Y.H., Armstrong, D., Albrecht, U., Atkins, C.M., Noebels, J.L., Eichele, G.,
Sweatt, J.D. and Beaudet, A.L. (1998) Mutation of the Angelman ubiquitinligase in mice causes increased cytoplasmic p53 and deﬁcits of contextual
learning and long-term potentiation. Neuron 21, 799–811.
[85] Weeber, E.J. et al. (2003) Derangements of hippocampal calcium/calmodulin-
dependent protein kinase II in a mouse model for Angelman mental
retardation syndrome. J. Neurosci. 23, 2634–2644.
[86] Su, H. et al. (2011) Mitochondrial dysfunction in CA1 hippocampal neurons of
the UBE3A deﬁcient mouse model for Angelman syndrome. Neurosci. Lett.
487, 129–133.
[87] Dindot, S.V., Antalffy, B.A., Bhattacharjee, M.B. and Beaudet, A.L. (2008) The
Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus,
and maternal deﬁciency results in abnormal dendritic spine morphology.
Hum. Mol. Genet. 17, 111–118.
[88] Yashiro, K. et al. (2009) Ube3a is required for experience-dependent
maturation of the neocortex. Nat. Neurosci. 12, 777–783.
[89] Greer, P.L. et al. (2010) The Angelman Syndrome protein Ube3A regulates
synapse development by ubiquitinating arc. Cell 140, 704–716.
[90] Kuhnle, S., Mothes, B., Matentzoglu, K. and Scheffner, M. (2013) Role of the
ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc.
Proc. Natl. Acad. Sci. U.S.A. 110, 8888–8893.
[91] Cao, C. et al. (2013) Impairment of TrkB-PSD-95 signaling in Angelman
syndrome. PLoS Biol. 11, e1001478.
[92] Margolis, S.S. et al. (2010) EphB-mediated degradation of the RhoA GEF
Ephexin5 relieves a developmental brake on excitatory synapse formation.
Cell 143, 442–455.
[93] Brooks, S.S., Wisniewski, K. and Brown, W.T. (1994) New X-linked mental
retardation (XLMR) syndrome with distinct facial appearance and growth
retardation. Am. J. Med. Genet. 51, 586–590.
[94] Froyen, G. et al. (2008) Submicroscopic duplications of the hydroxysteroid
dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated
with mental retardation. Am. J. Hum. Genet. 82, 432–443.
[95] Zhao, X. et al. (2009) The N-Myc-DLL3 cascade is suppressed by the ubiquitin
ligase Huwe1 to inhibit proliferation and promote neurogenesis in the
developing brain. Dev. Cell 17, 210–221.
[96] Mouchantaf, R., Azakir, B.A., McPherson, P.S., Millard, S.M., Wood, S.A. and
Angers, A. (2006) The ubiquitin ligase itch is auto-ubiquitylated in vivo and
in vitro but is protected from degradation by interacting with the
deubiquitylating enzyme FAM/USP9X. J. Biol. Chem. 281, 38738–38747.
[97] Xie, Y. et al. (2013) Deubiquitinase FAM/USP9X interacts with the E3
ubiquitin ligase SMURF1 protein and protects it from ligase activity-
dependent self-degradation. J. Biol. Chem. 288, 2976–2985.
[98] Homan, C.C. et al. (2014) Mutations in USP9X are associated with X-linked
intellectual disability and disrupt neuronal cell migration and growth. Am. J.
Hum. Genet. 94, 470–478.
[99] Lackovic, J., Howitt, J., Callaway, J.K., Silke, J., Bartlett, P. and Tan, S.S. (2012)
Differential regulation of Nedd4 ubiquitin ligases and their adaptor protein
Ndﬁp1 in a rat model of ischemic stroke. Exp. Neurol. 235, 326–335.
[100] Li, Z. and Sacks, D.B. (2003) Elucidation of the interaction of calmodulin with
the IQ motifs of IQGAP1. J. Biol. Chem. 278, 4347–4352.
[101] Basel-Vanagaite, L. et al. (2012) Deﬁciency for the ubiquitin ligase UBE3B in a
blepharophimosis-ptosis-intellectual-disability syndrome. Am. J. Hum.
Genet. 91, 998–1010.
[102] Basel-Vanagaite, L. et al. (2014) Expanding the clinical and mutational
spectrum of Kaufman oculocerebrofacial syndrome with biallelic UBE3B
mutations. Hum. Genet. 133, 939–949.
[103] Flex, E. et al. (2013) Loss of function of the E3 ubiquitin-protein ligase UBE3B
causes Kaufman oculocerebrofacial syndrome. J. Med. Genet. 50, 493–499.
[104] Pedurupillay, C.R. et al. (2015) Kaufman oculocerebrofacial syndrome in
sisters with novel compound heterozygous mutation in UBE3B. Am. J. Med.
Genet. 167, 657–663.
[105] Chahrour, M.H. et al. (2012) Whole-exome sequencing and homozygosity
analysis implicate depolarization-regulated neuronal genes in autism. PLoS
Genet. 8, e1002635.
[106] Bayes, A., Collins, M.O., Croning, M.D., van de Lagemaat, L.N., Choudhary, J.S.
and Grant, S.G. (2012) Comparative study of human and mouse postsynaptic
proteomes ﬁnds high compositional conservation and abundance differences
for key synaptic proteins. PLoS ONE 7, e46683.
[107] O’Roak, B.J. et al. (2012) Sporadic autism exomes reveal a highly
interconnected protein network of de novo mutations. Nature 485, 246–250.
[108] Meng, L., Ward, A.J., Chun, S., Bennett, C.F., Beaudet, A.L. and Rigo, F. (2015)
Towards a therapy for Angelman syndrome by targeting a long non-coding
RNA. Nature 518, 409–412.
[109] Mund, T., Lewis, M.J., Maslen, S. and Pelham, H.R. (2014) Peptide and small
molecule inhibitors of HECT-type ubiquitin ligases. Proc. Natl. Acad. Sci.
U.S.A. 111, 16736–16741.
[110] Scheiffele, P. and Beg, A.A. (2010) Neuroscience: Angelman syndrome
connections. Nature 468, 907–908.
